Bildkälla: Stockfoto

BioInvent: First Clinical Data on BI-1607 - Redeye

Redeye comments on the first phase I clinical data on BI-1607 communicated yesterday by BioInvent.

Redeye comments on the first phase I clinical data on BI-1607 communicated yesterday by BioInvent.
Börsvärldens nyhetsbrev
ANNONSER